Three Tickers Nobody's Talking About — But Should Be: ELAN, MITK, and SWIM

While the internet was busy eulogizing $AVGO after its AI guidance miss, a screwworm crawled into a calf in the southern U.S. and quietly handed $ELAN (Elanco Animal Health) one of the most specific, time-sensitive catalysts in biotech. The USDA is stockpiling treatments, three companies make them, and Elanco just got the first conditionally approved product — Credelio Quattro — for New World Screwworm. With a market cap under $5B and CEO Jeffrey Simmons already on CNBC, this isn't radar-level anymore, but it's still priced like nobody noticed. The outbreak is in early stages. The stockpile build is coming.

Next up: $MITK (Mitek Systems), a digital identity verification company that's basically a cockroach in the best way — small, unglamorous, impossible to kill. Bloomberg's coverage of Mozilla's 'Mythos' AI tool finding hundreds of Firefox vulnerabilities is a blinking neon sign for identity security infrastructure demand. Mitek sits at the unsexy intersection of fraud prevention and AI-enabled threat escalation. Sub-$400M market cap, sticky enterprise contracts, and a sector that's about to get a massive policy and spending tailwind.

$SWIM (Latham Group), the largest designer of inground residential pools in North America, sounds boring until you realize the housing delisting surge — 5.8% of listings pulled in April per Redfin data — means homeowners are stuck and renovating instead of moving. Pools. They're building pools. Latham is sub-$500M market cap, beaten down with housing sentiment, and sitting on a coiled spring if mortgage rates dip even slightly. Sometimes the most contrarian trade is the most obvious one.